Smooth Drug Development — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Smooth Drug Development is a privately held, revenue-generating CRO providing comprehensive clinical trial services from study design to regulatory submission. Its core differentiator is a proprietary, integrated Clinical Trial Management System (CTMS) that centralizes key trial functions like ePRO, IWRS, and eTMF. While lacking a proprietary therapeutic pipeline, the company leverages its technology platform and geographic execution capabilities in Europe and Asia to offer cost-effective and efficient trial management for pharmaceutical clients. Its multiple ISO certifications underscore a commitment to quality and reliability in a service-based business model.

Clinical ResearchDrug Development

Technology Platform

Proprietary, integrated Clinical Trial Management System (CTMS) with modules for ePRO, IWRS, EDC, eTMF/eISF, and data management.

Opportunities

Growing demand for CRO services in Europe and Asia provides a regional niche.

Increased outsourcing of generic drug development (bioequivalence studies) and the need for cost-effective, technology-enabled trial management from small-to-mid-sized biopharma firms represent key growth avenues.

Risk Factors

Faces intense competition from large global and niche CROs.

Revenue is project-dependent and susceptible to client concentration and biopharma R&D cycles.

Operational risks include trial execution failures, data security breaches, and regulatory compliance issues in its core geographic markets.

Competitive Landscape

Operates in the highly fragmented and competitive global CRO market. Competes with large, full-service CROs (e.g., IQVIA, ICON) on capability and with smaller, regional CROs on cost and niche expertise. Differentiation is based on its integrated CTMS platform and focused geographic execution in Europe/Asia.

More companies in United States →